Files

brevet2.pdf
  • Open Access
  • Adobe PDF
  • 93.26 KB

Details

Authors
Abstract
The disclosure is directed to crystalline forms and mixtures thereof of R-fasoracetam. Such crystalline forms include Form II monohydrate R-fasoracetam and the anhydrate form of R-fasoracetam. The disclosure further includes mixtures of the anhydrate form of R-fasoracetam together with one or more of Form I monohydrate R-fasoracetam and Form II monohydrate R-fasoracetam
Affiliations

Citations

Leyssens, T., & Harmsen, B. (2019). FASORACETAM CRYSTALLINE FORMS. https://hdl.handle.net/2078.5/29927